Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors

Sivgin, Serdar; Karakuş, Esen; Keklik, MUZAFFER; ZARARSIZ, GÖKMEN; Solmaz, Musa; Kaynar, LEYLAGÜL; Eser, BÜLENT; Cetin, MUSTAFA; Unal, ALİ

doi:10.1016/j.transci.2016.03.003

Evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors

Atıf İçin Kopyala

Sivgin S., Karakuş E., Keklik M., ZARARSIZ G., Solmaz M., Kaynar L., ...Daha Fazla

TRANSFUSION AND APHERESIS SCIENCE, cilt.54, sa.3, ss.410-415, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 54 Sayı: 3
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.transci.2016.03.003
Dergi Adı: TRANSFUSION AND APHERESIS SCIENCE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.410-415
Anahtar Kelimeler: Allogeneic hematopoietic stem cell transplantation, Stem cell mobilization, G-CSF, Biosimilars, COLONY-STIMULATING FACTOR, FEBRILE NEUTROPENIA, G-CSF, BREAST-CANCER, CHEMOTHERAPY, DURATION, XM02, LYMPHOMA, PRODUCT
Erciyes Üniversitesi Adresli: Evet

Özet

Objectives and Aim: In this study, we aimed to compare the potency of different G-CSF agents including original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) on CD34(+) cell mobilization in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT).